The condition formerly called polycystic ovarian syndrome has been renamed polyendocrine metabolic ovarian syndrome approximately two months ago to better capture the full range of its symptoms and allow for the potential identification of a male form of the condition. The hormone health issue typically emerges around the time of the first menstrual cycle and commonly presents with irregular periods, facial hair growth, pain, weight gain, and depression.
Women of color, particularly Black and Latina women, experience significantly higher rates of the condition compared to white women. Black women tend to experience more severe symptoms including hirsutism and hypertension, while Hispanic and Latina women face greater metabolic complications. Both groups encounter delayed diagnoses, healthcare access barriers, limited health insurance coverage, and elevated risks of mood disorders. More than 5 million women and girls of reproductive age in the United States live with the condition, and the World Health Organization estimates that up to 70% of people with it remain undiagnosed.
The diagnostic process presents substantial challenges. Without a single definitive test, physicians rely on exclusionary criteria, checking for two of three presentations: irregular or absent ovulation, hyperandrogenism, or ovaries with accumulated small follicles. Research indicates that many physicians have significant knowledge gaps in diagnosing and treating the condition, with more than one-third incorrectly associating “cysts on ovaries” with it. The original name’s emphasis on cystic presentation led doctors to overlook metabolic and fertility issues even when patients exhibited these symptoms.
Experts anticipate that the name change will improve recognition and accelerate diagnosis. However, experts emphasize that educational efforts must extend beyond the medical community to reach affected populations. Healthcare access remains a critical concern, particularly for immigrant communities facing policy changes that may result in loss of insurance coverage. Medical professionals stress the need for increased investment in research, education, and clinical support focused on women’s health, alongside community-based awareness initiatives to address longstanding disparities in diagnosis and treatment.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI